Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pingu
    Member
    • Jul 2015
    • 26

    #1

    Alignment reads

    Hello!
    Do you suggest to align reads against whole genome or only chromosome?
    I remembered that I have read that it is better to use whole genome (but I do not find the paper, if there is a paper when I can find it, could you send me the link?).
    Thank you very much in advance

    Best regards
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Are you thinking of aligning to "known" transcriptome vs whole genome for RNAseq data?

    Aligning to individual chromosomes (and combining that data) is no different would be roughly equivalent vs aligning to whole genome in one go.
    Last edited by GenoMax; 11-20-2015, 06:52 AM. Reason: clarification based on @SylvainL's point

    Comment

    • SylvainL
      Senior Member
      • Feb 2012
      • 180

      #3
      Originally posted by GenoMax View Post
      Aligning to individual chromosomes (and combining that data) is no different vs aligning to whole genome in one go.
      It depends if you remove multiple reads...

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        I was thinking of a simple case based on @pingu's description (against whole genome or only chromosome). Total data there is the same.

        But as you point out, the alignments would be (roughly) equivalent only with specified caveats e.g. keeping all alignments when reads multimap irrespective of the number of alignments.

        Comment

        • pingu
          Member
          • Jul 2015
          • 26

          #5
          Thank very much for your response. I am working with DNA, in particular with amplicons for BRCA1 and BRCA2, and I have the reference sequence (brca1 and brca2) but I think that it is better to align with whole genome in order to avoid to get false alignments. Is it true?
          Thank you for you help!

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            What downstream analysis are you planning to do?

            Comment

            • pingu
              Member
              • Jul 2015
              • 26

              #7
              I would like to find variants, in a diagnostic sector (I am working in a hospital).

              Comment

              • Brian Bushnell
                Super Moderator
                • Jan 2014
                • 2709

                #8
                For whole-genome shotgun it's important to align to the whole genome, or you will get false-positive hits. For amplicon sequencing, though, I doubt it would make much difference. I suggest you map a few to the whole genome to see if they hit anything other than the intended target (due to pseudogenes or homologous sequences that may also be caught by the same primers). If all the reads only map on-target, then there's no point in mapping against the whole genome.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                  by SEQadmin2



                  Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                  Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                  ...
                  10-14-2026, 09:55 AM
                • SEQadmin2
                  New Genomics Technologies Take Aim at Long-Standing Limits
                  by SEQadmin2


                  Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                  We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                  ...
                  09-28-2026, 10:25 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Yesterday, 11:13 AM
                0 responses
                16 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, Yesterday, 10:48 AM
                0 responses
                17 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-15-2026, 10:52 AM
                0 responses
                35 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-14-2026, 05:39 AM
                0 responses
                42 views
                0 reactions
                Last Post SEQadmin2  
                Working...